Subcutaneous

Health and Safety Factors. The following toxicities have been reported for cyanoacetic acid oral LD q (rat) 1500 mg/kg subcutaneous LD q (rabbit), 1900 mg/kg and subcutaneous LD q (frog) 1300 mg/kg (29). Eor ethyl cyanoacetate the following toxicities have been reported interperitoneal LD q (mice), 750 mg/kg subcutaneous LD q (rabbits), 1500 mg/kg and subcutaneous LD q (frogs), 4000 mg/kg. 

The only reported toxicity data on zinc fluoride in the NIOSH RTECS file is a LD q of 280 mg/kg for subcutaneous adniinistration in frogs. 

Classification of the anabolic steroids is based on chemical stmctures and associated actions. A review of the biosynthesis and metabolism of the naturally occurring estrogens and androgens is available (1). Names, descriptions, approval dates, and recommended doses of the commercial products are found in References 1, 8, and 9. Although steroids may be orally active, the FDA approved mode of adrninistration is the subcutaneous implant. Effective dose is lower with implant rather than oral adrninistration. 

Very Htfle data are available regarding effects of anaboHc steroid implants on the Hpid metaboHsm in growing mminants. Lipogenic enzyme activity and fatty acid synthesis in vitro were elevated in subcutaneous adipose tissue from bulls implanted with estradiol (44), which may account for the increase in fat content of carcasses reported in some studies. TBA implants have no effect on Hpogenesis in intact heifers, and only tend to reduce Hpogenic enzyme activities in ovariectomized heifers (45). 

Pituitary Dwarfism. Pituitary dwarfism is a condition characterized by an inabiHty to produce or secrete normal levels of endogenous hGH. The condition results in reduced heights of individuals afflicted with the condition and has been treated by intramuscular or subcutaneous injection of hGH. Pituitary hGH was used prior to the approval of biosynthetic hGH. If treatment is initiated early enough, the patient can attain a final adult height weU within the normal range. 

NPH Isophane Human Insulin Suspension. NPH isophane insulin, also called Humulin N, Insulatard NPH Human, or Novolin N is an intermediate-acting form of human insulin produced by recombinant DNA techniques. Mixtures Humulin 70/30 and Novolin 70/30 contain 70% NPH isophane and 30% regular, whereas Humulin 50/50 contains 50% NPH isophane and 50% regular. It is adrninistered subcutaneously and should not be given intravenously. Absorption is delayed because the insulin is conjugated with protamine in a complex of reduced isoelectric solubiUty. Therapeutically, this preparation is probably comparable to purified porcine NPH insulin. However, human NPH insulin may have a slightly shorter duration of action than comparable purified porcine products. 

Barium peroxide is a strong oxidizer and can cause fire when in contact with combustible materials. It is a powerful irritant to skin, eyes, and mucous membranes (2). Consequendy, it is also toxic via the subcutaneous route protective clothing should be worn during handling. The LD q value (mouse, oral) is 50 mg/kg (2). 

Intravenous aqueous injections provide an excellent means of achieving a rapid therapeutic response. Parenteral product design, eg, vehicle and other excipient selection, as well as choice of route of adrninistration, can prolong therapeutic activity and increase onset times. Thus, oily solutions, suspensions, or emulsions can be adrninistered by subcutaneous or intramuscular routes to create prolonged effect, ie, depot injection (28). 

Strong acids and strong alkaUes can severely bum the skin, chromium compounds can produce skin rashes, and repeated exposure to solvents causes removal of natural oils from the skin. Infection is always a concern for damaged skin. Absorption through the skin is possible for materials that are appreciably soluble iu both water and oil, eg, nitrobenzene, aniline, and tetraethyllead. Other materials can be absorbed if first dissolved iu extremely good solvents, eg, dimethyl sulfoxide. Subcutaneous iujection can occur accidentally by direct exposure of the circulatory system to a chemical by means of a cut or scratch or iuadvertent penetration of the skin with a hypodermic needle. 

Elaborate precautions must be taken to prevent the entrance of Pu iato the worker s body by ingestion, inhalation, or entry through the skin, because all common Pu isotopes except for Pu ate a-emitters. Pu is a P-emitter, but it decays to Am, which emits both (X- and y-rays. Acute intake of Pu, from ingestion or a wound, thus mandates prompt and aggressive medical intervention to remove as much Pu as possible before it deposits in the body. Subcutaneous deposition of plutonium from a puncture wound has been effectively controlled by prompt surgical excision followed by prolonged intravenous chelation therapy with diethylenetriaminepentaacetate (Ca " —DTPA) (171). 

Tolypomycin Y (48) shows strong antibacterial activity against gram-positive bacteria and Neisseriagonorrheae. When adininistered by subcutaneous, intraperitoneal, and intravenous routes, tolypomycin Y is effective in mice infected with Staphylococcus aureus Streptococcuspyrogenes and Diplococcuspneumoniae. Cross-resistance is observed with rifampicia but not with other antibiotics. Resistance to tolypomycin Y develops rapidly. The bioactivity of tolypomycin R... 

In Vivo Effects of Florfenicol. Comparative acute toxicities of florfenicol, chloramphenicol, and thiamphenicol in mice ate given in Table 6. As can be seen, florfenicol is similar to thiamphenicol in acute toxicity by oral and subcutaneous (sc) adininistration, but is comparable to chloramphenicol by intraperitoneal (ip) and intravenous (iv) routes. Semm levels in mice following either a single or subcutaneous dose of 200 mg/kg of amphenicol have... 

The efficacy of florfenicol in vivo was determined by measuring the dose required to obtain values for protection from infection in 50% of the animals (PD q) against 10 chloramphenicol-resistant strains and two chloramphenicol-sensitive isolates. Florfenicol, chloramphenicol, and thiamphenicol were evaluated concurrendy against each strain. Against sensitive Enterobacter 50 subcutaneous and oral routes were similar for dorfenicol and... 

Blood Access Devices. An investigational device called the Osteoport system allows repeated access to the vascular system via an iatraosseous iafusion directiy iato the bone marrow. The port is implanted subcutaneously and secured iato a bone, such as the iUac crest. Medications are adrninistered as ia any conventional port, but are taken up by the venous sinusoids ia the marrow cavity, and from there enter the peripheral circulation (8). 

Placement of vascular access ports is similar to that of a long-term indwelling arterial catheter. A small incision is made over the selected vein and a second incision is made lower in the anterior chest to create a pocket to house the port. The catheter is tuimeled subcutaneously from its entry point into the vein with the tip inside the right atrium. The final position of the catheter is verified by fluoroscopy, secured with sutures, and the subcutaneous pocket is closed. The port septum is easily palpable transcutaneously, and the system may be used immediately. A surgeon typically inserts the vascular access port in an outpatient setting. 

---